US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 2.2000
  • -0.0400-1.79%
Close Nov 4 16:00 ET
3.15MMarket Cap0.06P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-28.04%2.82M
-42.32%3.71M
80.78%14.54M
-45.83%2.12M
211.92%2.07M
548.43%3.92M
124.55%6.43M
115.17%8.04M
328.01%3.91M
-23.97%663K
Selling and administrative expenses
63.17%1.46M
33.74%1.32M
-21.81%4.18M
-66.23%1.14M
147.55%1.16M
97.36%896K
-6.73%984K
115.18%5.35M
542.56%3.37M
-21.04%469K
-General and administrative expense
63.17%1.46M
33.74%1.32M
-21.81%4.18M
-66.23%1.14M
147.55%1.16M
97.36%896K
-6.73%984K
115.18%5.35M
542.56%3.37M
-21.04%469K
Research and development costs
-55.04%1.36M
-56.07%2.39M
284.03%10.36M
80.18%982K
367.53%907K
1,904.64%3.03M
201.16%5.45M
115.15%2.7M
39.74%545K
-30.22%194K
Operating profit
28.04%-2.82M
42.32%-3.71M
-80.78%-14.54M
45.83%-2.12M
-211.92%-2.07M
-548.43%-3.92M
-124.55%-6.43M
-115.17%-8.04M
-328.01%-3.91M
23.97%-663K
Net non-operating interest income expense
-8.77%52K
116.61%49K
81.93%-206K
101.92%22K
800.00%9K
5,600.00%57K
-14,850.00%-295K
-16,385.71%-1.14M
-114,500.00%-1.14M
0.00%1K
Non-operating interest income
-8.77%52K
32.43%49K
530.00%126K
37.50%22K
800.00%9K
5,600.00%57K
1,750.00%37K
185.71%20K
1,500.00%16K
0.00%1K
Non-operating interest expense
--0
--0
-71.38%332K
--0
--0
--0
--332K
--1.16M
--1.16M
--0
Other net income (expense)
146.67%70K
21.41%-690K
-23.69%4.26M
2.71M
2.57M
-150K
-878K
5.58M
Gain on sale of security
146.67%70K
21.41%-690K
-23.69%4.26M
--2.71M
--2.57M
---150K
---878K
--5.58M
----
----
Income before tax
32.74%-2.7M
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
Income tax
Net income
32.74%-2.7M
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
Net income continuous Operations
32.74%-2.7M
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
Minority interest income
0.00%-9K
86.36%-9K
-117.65%-111K
54.90%-23K
-13K
-9K
-66K
-51K
-51K
0
Net income attributable to the parent company
-79.34%-7.19M
42.41%-4.34M
-192.15%-10.38M
11.30%640K
179.46%526K
-563.41%-4.01M
-163.40%-7.54M
4.80%-3.55M
162.98%575K
24.00%-662K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-79.34%-7.19M
42.41%-4.34M
-192.15%-10.38M
11.30%640K
179.46%526K
-563.41%-4.01M
-163.40%-7.54M
4.80%-3.55M
162.98%575K
24.00%-662K
Basic earnings per share
83.40%-6.43
84.84%-15.4
39.88%-73.5
-79.24%1.8752
113.33%4.5
-25.98%-38.74
33.94%-101.57
50.46%-122.25
116.28%9.0336
43.04%-33.75
Diluted earnings per share
83.40%-6.43
84.84%-15.4
39.88%-73.5
-79.24%1.8752
113.33%4.5
-25.98%-38.74
33.94%-101.57
50.46%-122.25
116.28%9.0336
43.04%-33.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -28.04%2.82M-42.32%3.71M80.78%14.54M-45.83%2.12M211.92%2.07M548.43%3.92M124.55%6.43M115.17%8.04M328.01%3.91M-23.97%663K
Selling and administrative expenses 63.17%1.46M33.74%1.32M-21.81%4.18M-66.23%1.14M147.55%1.16M97.36%896K-6.73%984K115.18%5.35M542.56%3.37M-21.04%469K
-General and administrative expense 63.17%1.46M33.74%1.32M-21.81%4.18M-66.23%1.14M147.55%1.16M97.36%896K-6.73%984K115.18%5.35M542.56%3.37M-21.04%469K
Research and development costs -55.04%1.36M-56.07%2.39M284.03%10.36M80.18%982K367.53%907K1,904.64%3.03M201.16%5.45M115.15%2.7M39.74%545K-30.22%194K
Operating profit 28.04%-2.82M42.32%-3.71M-80.78%-14.54M45.83%-2.12M-211.92%-2.07M-548.43%-3.92M-124.55%-6.43M-115.17%-8.04M-328.01%-3.91M23.97%-663K
Net non-operating interest income expense -8.77%52K116.61%49K81.93%-206K101.92%22K800.00%9K5,600.00%57K-14,850.00%-295K-16,385.71%-1.14M-114,500.00%-1.14M0.00%1K
Non-operating interest income -8.77%52K32.43%49K530.00%126K37.50%22K800.00%9K5,600.00%57K1,750.00%37K185.71%20K1,500.00%16K0.00%1K
Non-operating interest expense --0--0-71.38%332K--0--0--0--332K--1.16M--1.16M--0
Other net income (expense) 146.67%70K21.41%-690K-23.69%4.26M2.71M2.57M-150K-878K5.58M
Gain on sale of security 146.67%70K21.41%-690K-23.69%4.26M--2.71M--2.57M---150K---878K--5.58M--------
Income before tax 32.74%-2.7M42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K
Income tax
Net income 32.74%-2.7M42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K
Net income continuous Operations 32.74%-2.7M42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K
Minority interest income 0.00%-9K86.36%-9K-117.65%-111K54.90%-23K-13K-9K-66K-51K-51K0
Net income attributable to the parent company -79.34%-7.19M42.41%-4.34M-192.15%-10.38M11.30%640K179.46%526K-563.41%-4.01M-163.40%-7.54M4.80%-3.55M162.98%575K24.00%-662K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -79.34%-7.19M42.41%-4.34M-192.15%-10.38M11.30%640K179.46%526K-563.41%-4.01M-163.40%-7.54M4.80%-3.55M162.98%575K24.00%-662K
Basic earnings per share 83.40%-6.4384.84%-15.439.88%-73.5-79.24%1.8752113.33%4.5-25.98%-38.7433.94%-101.5750.46%-122.25116.28%9.033643.04%-33.75
Diluted earnings per share 83.40%-6.4384.84%-15.439.88%-73.5-79.24%1.8752113.33%4.5-25.98%-38.7433.94%-101.5750.46%-122.25116.28%9.033643.04%-33.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data